Icon

DAUNORUBICIN HYDROCHLORIDE (nda050731)- (EQ 5MG BASE/ML)

DAUNORUBICIN HYDROCHLORIDE HIKMA
EQ 5MG BASE/ML
No No
Expired Expired
None None
None No
Daunorubicin hydrochloride in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.
3 0 2
Total Other Developers None
Drugs with Suitability No
EQ 5MG BASE/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ***** ******** ***** ************** (********) **., ***. *********** **.*, ******** ****, ***** ****, ****** ********, ********, ******** ******, ***** (***) ***
****** ***** ***** ******** ***** ************** (********) **., ***. *** *********** **.*, ******** ****, ***** ****, ****** ********, ********, ******** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.